Rearguard Battle At Takeda Unlikely To Derail Globalization Plans
This article was originally published in PharmAsia News
Executive Summary
The planned appointment of Christophe Weber as chief operating officer at Asia’s leading pharmaceutical company has ruffled feathers among traditionalists fearful of change.